INTRODUCTION
Lignin is an abundant biopolymer in the cell walls of vascular plants, where its hydrophobic, aromatic moieties linked by C–C and C–O bonds support and protect plant tissues. This critical polymer comprises up to 30% of biomass and 30% of organic carbon on earth (
1). In plants, lignin is synthesized by radical coupling of phenolics, including hydroxycinnamyl acid derivatives, most of which have at least one methoxy substituent (
2). The polymer is therefore complex, irregular, and highly methoxylated (
Fig. 1A). Due to its abundance, lignin is an attractive, renewable feedstock to displace fossil fuels for the sustainable manufacturing of chemicals such as dicarboxylic acids, lipids, and aromatics (
3). However, its heterogeneity, reactivity, and association with plant polysaccharides present significant barriers to its valorization. The use of tandem processes that integrate chemical and biological catalysis has emerged as a promising strategy for lignin valorization (
4–6). In these processes, thermochemical fractionation of the biomass yields a mixture of lignin-derived aromatic compounds (LDACs), which is then transformed by a microbial cell factory into a single, target compound. Biocatalysis exploits the naturally convergent nature of aromatic catabolism in bacteria (
6). However, efficient production of the target compound requires that the biocatalyst be tuned to the mixture of LDACs, whose composition depends on the biomass and the chemo-catalytic depolymerization process (
4).
A variety of methods have been developed for depolymerizing lignin, the majority of which primarily cleave the C–O linkages (
3,
15–17). For example, reductive catalytic fractionation (RCF) cleaves the C–O bonds in lignin to near theoretical yields (
18). Unfortunately, the C–C linkages are recalcitrant to RCF and many other methods (
19), leaving many lignin aromatics inaccessible in dimeric and oligomeric structures. To overcome this limitation, emerging chemo-catalytic strategies target C–C linkages with oxidation (
20,
21). As one example, Palumbo et al. recently reported C–C bond cleavage catalysis of the dimers and oligomers in pine RCF lignin oil through radical autoxidation, in a process that requires the protection of the phenol groups due to their antioxidant nature. Phenol protection by methylation enabled autoxidation with a Mn/Zr catalyst system, yielding a lignin stream enriched in the monomeric compounds veratrate, veratraldehyde, and
p-methoxybenzoate (
p-MBA) (
Fig. 1B) (
7). As the major LDACs in this lignin stream are
p-methylated, the discovery and characterization of
p-O-demethylation pathways and enzymes are imperative for developing effective biocatalysts. Indeed, metabolic engineering has revealed that
O-demethylation is a potentially rate-limiting step in the biocatalytic transformation of LDACs (
22), and
p-O-demethylation pathways are not native to some of the strains being developed as microbial cell factories, such as
Pseudomonas putida KT2440 (
7).
Rieske-type oxygenases (ROs) and cytochromes P450 (P450s) are two families of enzymes that are widespread in bacteria and that catalyze the
O-demethylation of LDACs (
22). ROs and P450s utilize a mononuclear iron or heme prosthetic group, respectively, to activate dioxygen for the
O-demethylation reaction. Both the RO- and P450-catalyzed reactions require two reducing equivalents, typically originating from NAD(P)H, and result in the production of water and formaldehyde. Electron transfer from NAD(P)H to the oxygenase is mediated by a flavin-containing reductase through a ferredoxin domain, which can either be linked to the reductase domain or can occur as a separate component (
23). The architecture of these reductases varies. For example, the respective reductases of the phthalate dioxygenase (
24) and vanillate
O-demethylase (
25) systems are characterized by an N-terminal flavin-containing domain and a C-terminal 2Fe-2S-containing domain. Interestingly, homologous “phthalate dioxygenase reductase” (PDR)-type components have been reported as part of two-component P450-reductase systems (
26). Among ROs and P450s catalyzing
O-demethylation, several have been reported to act on
p-methoxylated LDACs (
Fig. 1B). For example, ROs catalyze the
p-O-demethylation of
p-MBA and veratrate in pseudomonads and
Comamonas testosteroni, respectively (
8,
9). Similarly, P450
RR2 was induced in
Rhodococcus rhodochrous strain 116 by growth on
p-MBA and
p-ethoxybenzoate (
11). P450
RR2 bound
p-MBA tightly, suggesting the enzyme catalyzes the
O-demethylation of this compound. More recently, several members of the P450 subfamily CYP199A were shown to selectively
p-O-demethylate
p-MBA and veratrate although the subsequent catabolism of these compounds was not fully elucidated (
12–14). However, the CYP199A4 system from
Rhodopseudomonas palustris has been expressed in engineered strains of
P. putida KT2440 for catabolism of
p-methoxylated LDACs from RCF (
7).
Rhodococcus is a genus of bacteria that catabolizes an exceptionally wide range of aromatic compounds (
27,
28). Growth substrates include alkylguaiacols and acetovanillone, which are derived from the chemocatalytic fractionation of diverse biomass feedstocks (
7,
29–32). Their catabolic capacity, combined with their high resistance to stressors such as organic solvents, contribute to rhodococci being ideal candidates for biocatalysis (
33), and indeed, rhodococcal biocatalysts are used to generate thousands of tons of acrylamide annually (
34). The engineering and optimization of rhodococcal biocatalysts are further assisted by the availability of numerous genetic tools (
35–37). Within this genus,
Rhodococcus jostii RHA1 (RHA1 hereafter), originally isolated from lindane-contaminated soil, has been well characterized for its ability to catabolize a variety of aromatic compounds and steroids (
38,
39). Relevant to this study, RHA1’s ability to catabolize veratraldehyde and veratrate has not been investigated. However, the catabolism of their
p-O-demethylated counterparts, vanillin and vanillate, respectively, have been described (
40). Briefly, a vanillin dehydrogenase, Vdh, catalyzes the oxidation of vanillin to vanillate, and the two-component RO, VanAB, catalyzes the
O-demethylation of vanillate to protocatechuate. Protocatechuate is catabolized to central metabolites via the β-ketoadipate pathway, which is encoded by the
pca genes (
41,
42). Indeed, although several bacterial strains have been reported to grow on veratraldehyde (
43,
44), the genetic basis for this catabolism has yet to be validated.
In this study, we evaluated the potential of RHA1 as a biocatalyst for the valorization of methylated lignin streams. To do this, we first tested the ability of RHA1 to utilize a methylated lignin stream as a growth substrate. We then elucidated the catabolic pathway of each of the major
p-methoxylated aromatic monomers in the mixture: veratraldehyde, veratrate, and
p-MBA. Catabolic pathways were elucidated by growth analysis of deletion mutants and investigating metabolite accumulation. These mutants included the previously constructed Δ
vdh, Δ
vanA (
40), and Δ
pcaL (
42) deletion mutants due to the chemical similarity of veratraldehyde and veratrate with vanillin and vanillate, respectively. The results are discussed with respect to establishing RHA1 as a viable biocatalyst to transform methylated lignin streams and, more generally, to the engineering and development of application-specific microbial cell factories for valorizing lignin.